Changes in treatment adherence and glycemic control during the transition to adolescence in type 1 diabetes.
prospective_cohort · Level II
Where this comes from
- Record sourced from PubMed, PMID 22474040.
- Also identified by DOI 10.2337/dc11-2163 and PMC identifier 3357213.
- Licence recorded as CC BY-NC-ND.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
To test models of unidirectional and bidirectional change between treatment adherence and glycemic control in youth with type 1 diabetes. We conducted a 2-year longitudinal, multisite study of 225 youth with type 1 diabetes recruited at the cusp of adolescence (aged 9-11 years) to describe the mutual influences of glycemic control as measured by HbA(1c) and treatment adherence as measured by blood glucose monitoring frequency (BGMF) during the transition to adolescence. HbA(1c) increased from 8.2 to 8.6% (P < 0.001) and BGMF decreased from 4.9 to 4.5 checks per day (P < 0.02) during the 2-year period. Changes in the BGMF slope predicted changes in HbA(1c). A change (increase) in HbA(1c) was associated with a change (decrease) in BGMF of 1.26 (P < 0.001) after controlling for covariates. The magnitude of the effect of declining treatment adherence (BGMF) on glycemic control in young adolescents may be even greater than declines observed among older adolescents. BGMF offers a powerful tool for targeted management of glycemic control for type 1 diabetes during the critical transition to adolescence.
Medical subject headings
- Adolescent Behavior
- Diabetes Mellitus, Type 1
- Hypoglycemic Agents
- Insulin
- Drug Monitoring